Drug Discovery

Penn's CNDR has created a unique drug development program which harnesses the team's biological understanding of neurodegenerative diseases and bridges the "valley of death" from lab research to pharmaceutical development.

The team investigates various drug targets and collaborates with industry partners on translational research projects.

For more details on the Drug Discovery Program, please contact:
Kurt Brunden, PhD
Email: kbrunden@upenn.edu
Office: 215-615-5262
Lab: 215-662-3292